Survey study of patient related outcomes (items) to be used in pancreatic cancer care and research.
Not Applicable
- Conditions
- Health Condition 1: null- Pancreas or periampullary
- Registration Number
- CTRI/2016/07/007124
- Lead Sponsor
- Tata Memorial Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 560
Inclusion Criteria
Patients with histo- or cytopathologically proven pancreatic or periampullary cancer diagnosed between January 2012 and July 2015 in the Johns Hopkins Hospital, Baltimore, the Massachusetts General Hospital, Boston, the Beth Israel Deaconess Medical Center, Boston (all USA),the University of Verona Hospital Trust, Verona, Italy, the Dutch Pancreatic Cancer Group (DPCG), Tata Memorial Centre, Mumbai, India and the Seoul National University Hospital, Seoul, South Korea will be identified and will receive an electronic invitation to participate in the survey
Exclusion Criteria
Patients with a life expectancy of less than three months are excluded to ensure completion of both rounds
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method